Oxycodone administered as postpartum pain relief is associated with maternal report of infant central nervous system depression in breastfed infants
- 1Department of Women's and Children's Health, Division of Reproductive Health, Karolinska Institute, Stockholm, Sweden
- 2Department of Psychology, University of Toronto at Mississauga, 3359 Mississauga Road N, Mississauga, ON L5L1C6, Canada
- Correspondence to: Wibke Christina Jonas
Department of Psychology, University of Toronto at Mississauga, 3359 Mississauga Road N, Mississauga, ON L5L1C6, Canada; Wibke.Jonas{at}ki.se
Commentary on:
Context
Despite our knowledge that codeine is excreted in breast milk, administration of codeine as a pain relief to breastfeeding mothers during the early postpartum period was considered safe until a healthy newborn died.1 The mother was an ultra-rapid metaboliser of codeine and thus, produced effectively the metabolite morphine. As a consequence, the guidelines for codeine use during breastfeeding were changed to include more caution about the possible central nervous system (CNS) depression effects on the neonate.2 As a result, many clinicians started to prescribe oxycodone, a semisynthetic opioid, instead. Little is known about the excretion of oxycodone into breast milk and the safety for newborns to mothers taking oxycodone while breastfeeding. Lam et al …
